Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Lehrer, Axel

One or more keywords matched the following items that are connected to Lehrer, Axel

Item Type	Name
Academic Article	Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.
Academic Article	Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4.
Academic Article	Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.
Academic Article	Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
Academic Article	Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: A preliminary report.
Concept	Ebolavirus
Grant	GH19-003, Epidemiology and Immunity to Ebola Virus and Other Emerging Viral Infections in Liberia
Grant	Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
Grant	Defining a Protective Ebola Vaccine in Non-Human Primates
Grant	Development of a Recombinant Subunit Ebola Vaccine
Academic Article	Preservation of Quaternary Structure in Thermostable, Lyophilized Filovirus Glycoprotein Vaccines: A Search for Stability-Indicating Assays.
Academic Article	Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.
Academic Article	Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Academic Article	Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model.
Academic Article	Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human Primates.
Academic Article	Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.

Search Criteria

Ebolavirus

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support